in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Lonza to Co-Develop Novartis Biologics Pipeline
12:17 PM MDT | July 21, 2008 | Deepti Ramesh
Lonza says it has entered into a long-term partnership with Novartis to jointly develop and manufacture Novartis’s biologics pipeline. Under the deal, Lonza will provide services from its R&D center at Slough, U.K. using its GS Gene Expression System as well as its large-scale manufacturing capacity from operations in Singapore, Spain, and the U.S. Kutzer: A change in approach. Novartis says it aims to further grow its biologics pipeline, which has risen during the last few years to about one-quarter of its total R&D portfolio. Novartis says its...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: